Cargando…
Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021
As of March 2021, three COVID-19 vaccines had been authorized by the U.S. Food and Drug Administration (FDA) for use in the United States. Each has substantial efficacy in preventing COVID-19. However, as efficacy from trials was <100% for all three vaccines, disease in vaccinated people is expec...
Autores principales: | Kugeler, Kiersten J., Williamson, John, Curns, Aaron T., Healy, Jessica M., Nolen, Leisha D., Clark, Thomas A., Martin, Stacey W., Fischer, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906607/ https://www.ncbi.nlm.nih.gov/pubmed/35263352 http://dx.doi.org/10.1371/journal.pone.0264179 |
Ejemplares similares
-
Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021
por: Sadigh, Katrin S., et al.
Publicado: (2022) -
COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
por: Birhane, Meseret, et al.
Publicado: (2021) -
Progress Toward Poliomyelitis Eradication — Pakistan, January 2020–July 2021
por: Mbaeyi, Chukwuma, et al.
Publicado: (2021) -
Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022
por: Mbaeyi, Chukwuma, et al.
Publicado: (2022) -
Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
por: Bassal, Ravit, et al.
Publicado: (2022)